Annual ROE
987.83%
+1302.41%+414.02%
01 December 2023
Summary:
Plus Therapeutics annual return on equity is currently 987.83%, with the most recent change of +1302.41% (+414.02%) on 01 December 2023. During the last 3 years, it has risen by +1381.10% (+351.18%). PSTV annual ROE is now at all-time high.PSTV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
271.49%
-201.52%-42.60%
01 September 2024
Summary:
Plus Therapeutics quarterly return on equity is currently 271.49%, with the most recent change of -201.52% (-42.60%) on 01 September 2024. Over the past year, it has increased by +1077.06% (+133.70%). PSTV quarterly ROE is now -94.81% below its all-time high of 5226.19%, reached on 01 March 2024.PSTV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +133.7% |
| 3 y3 years | +351.2% | +307.6% |
| 5 y5 years | +812.5% | +135.3% |
PSTV ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +351.2% | -94.8% | +133.7% |
| 5 y | 5 years | at high | +351.2% | -94.8% | +120.6% |
| alltime | all time | at high | +151.1% | -94.8% | +100.0% |
Plus Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 271.49%(-42.6%) |
| June 2024 | - | 473.01%(-90.9%) |
| Mar 2024 | - | 5226.19%(-748.8%) |
| Dec 2023 | 987.83%(-414.0%) | -805.57%(+91.3%) |
| Sept 2023 | - | -421.08%(+42.2%) |
| June 2023 | - | -296.10%(+6.7%) |
| Mar 2023 | - | -277.63%(+44.4%) |
| Dec 2022 | -314.58%(+154.4%) | -192.32%(+19.3%) |
| Sept 2022 | - | -161.27%(+16.5%) |
| June 2022 | - | -138.46%(+22.1%) |
| Mar 2022 | - | -113.42%(-0.4%) |
| Dec 2021 | -123.65%(-68.6%) | -113.92%(-12.9%) |
| Sept 2021 | - | -130.78%(-18.2%) |
| June 2021 | - | -159.87%(-25.3%) |
| Mar 2021 | - | -213.90%(-41.4%) |
| Dec 2020 | -393.27%(+15.3%) | -364.77%(+73.3%) |
| Sept 2020 | - | -210.44%(+63.3%) |
| June 2020 | - | -128.88%(-117.8%) |
| Mar 2020 | - | 724.62%(-154.9%) |
| Dec 2019 | -341.02%(+146.0%) | -1319.32%(+71.5%) |
| Sept 2019 | - | -769.28%(+25.0%) |
| June 2019 | - | -615.66%(+208.0%) |
| Mar 2019 | - | -199.91%(+19.0%) |
| Dec 2018 | -138.64%(-26.7%) | -168.03%(-8.0%) |
| Sept 2018 | - | -182.70%(-3.6%) |
| June 2018 | - | -189.51%(-7.2%) |
| Mar 2018 | - | -204.13%(-9.3%) |
| Dec 2017 | -189.16%(-0.5%) | -225.08%(-1.4%) |
| Sept 2017 | - | -228.31%(+18.4%) |
| June 2017 | - | -192.80%(-7.0%) |
| Mar 2017 | - | -207.34%(+19.1%) |
| Dec 2016 | -190.12%(-67.0%) | -174.08%(+0.4%) |
| Sept 2016 | - | -173.45%(+22.8%) |
| June 2016 | - | -141.30%(-46.6%) |
| Mar 2016 | - | -264.70%(-113.2%) |
| Dec 2015 | -576.38%(-187.9%) | 2010.62%(+400.3%) |
| Sept 2015 | - | 401.85%(-7.9%) |
| June 2015 | - | 436.34%(-30.9%) |
| Mar 2015 | - | 631.38%(-77.2%) |
| Dec 2014 | 655.35%(-220.0%) | 2768.07%(-103.3%) |
| Sept 2014 | - | -84.66 K%(+2066.7%) |
| June 2014 | - | -3907.33%(+61.6%) |
| Mar 2014 | - | -2418.35%(+85.3%) |
| Dec 2013 | -546.09%(+38.7%) | -1304.89%(+12.7%) |
| Sept 2013 | - | -1157.44%(-92.0%) |
| June 2013 | - | -14.38 K%(+509.6%) |
| Mar 2013 | - | -2359.53%(+105.6%) |
| Dec 2012 | -393.62% | -1147.37%(+26.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | -904.98%(+119.8%) |
| June 2012 | - | -411.69%(+42.0%) |
| Mar 2012 | - | -289.98%(+20.2%) |
| Dec 2011 | -197.76%(-30.9%) | -241.31%(-14.3%) |
| Sept 2011 | - | -281.46%(-2.3%) |
| June 2011 | - | -288.16%(+3.4%) |
| Mar 2011 | - | -278.72%(+2.5%) |
| Dec 2010 | -286.17%(-145.1%) | -271.82%(-48.5%) |
| Sept 2010 | - | -527.69%(-8.6%) |
| June 2010 | - | -577.55%(-93.8%) |
| Mar 2010 | - | -9280.83%(-1267.8%) |
| Dec 2009 | 634.66%(+63.1%) | 794.76%(+54.4%) |
| Sept 2009 | - | 514.72%(+5.6%) |
| June 2009 | - | 487.54%(+22.3%) |
| Mar 2009 | - | 398.70%(+10.5%) |
| Dec 2008 | 389.22%(+27.6%) | 360.87%(-7.7%) |
| Sept 2008 | - | 390.94%(-3.1%) |
| June 2008 | - | 403.33%(-43.9%) |
| Mar 2008 | - | 719.24%(-78.3%) |
| Dec 2007 | 305.02%(+29.6%) | 3320.56%(+103.0%) |
| Sept 2007 | - | 1635.92%(+163.9%) |
| June 2007 | - | 619.86%(+121.2%) |
| Mar 2007 | - | 280.19%(+42.2%) |
| Dec 2006 | 235.34%(-129.3%) | 197.05%(-38.8%) |
| Sept 2006 | - | 322.05%(-15.9%) |
| June 2006 | - | 382.80%(-100.0%) |
| Mar 2006 | - | -1.13 M%(>+9900.0%) |
| Dec 2005 | -803.69%(+5233.0%) | -525.82%(+210.1%) |
| Sept 2005 | - | -169.56%(+100.0%) |
| June 2005 | - | -84.76%(+40.8%) |
| Mar 2005 | - | -60.22%(+325.9%) |
| Dec 2004 | -15.07%(-66.8%) | -14.14%(-309.5%) |
| Sept 2004 | - | 6.75%(-118.0%) |
| June 2004 | - | -37.42%(+55.5%) |
| Mar 2004 | - | -24.07%(-46.4%) |
| Dec 2003 | -45.39%(+12.5%) | -44.90%(-23.6%) |
| Sept 2003 | - | -58.77%(+9.7%) |
| June 2003 | - | -53.58%(+15.0%) |
| Mar 2003 | - | -46.59%(+14.0%) |
| Dec 2002 | -40.33%(+58.0%) | -40.87%(+37.3%) |
| Sept 2002 | - | -29.77%(+12.1%) |
| June 2002 | - | -26.55%(-17.8%) |
| Mar 2002 | - | -32.30%(+34.5%) |
| Dec 2001 | -25.52%(-36.2%) | -24.01%(+46.5%) |
| Sept 2001 | - | -16.39%(+67.9%) |
| June 2001 | - | -9.76% |
| Dec 2000 | -40.03%(-153.8%) | - |
| Dec 1999 | 74.36%(-103.8%) | - |
| Dec 1998 | -1935.19% | - |
FAQ
- What is Plus Therapeutics annual return on equity?
- What is the all time high annual ROE for Plus Therapeutics?
- What is Plus Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Plus Therapeutics?
- What is Plus Therapeutics quarterly ROE year-on-year change?
What is Plus Therapeutics annual return on equity?
The current annual ROE of PSTV is 987.83%
What is the all time high annual ROE for Plus Therapeutics?
Plus Therapeutics all-time high annual return on equity is 987.83%
What is Plus Therapeutics quarterly return on equity?
The current quarterly ROE of PSTV is 271.49%
What is the all time high quarterly ROE for Plus Therapeutics?
Plus Therapeutics all-time high quarterly return on equity is 5226.19%
What is Plus Therapeutics quarterly ROE year-on-year change?
Over the past year, PSTV quarterly return on equity has changed by +1077.06% (+133.70%)